NCT04422483

Brief Summary

Diagnostic pathways for children with possible autism. Which work best, for whom, when, and at what cost? Autism is a complex neuro-behaviour condition. People with autism have difficulty with social interaction and in communication with others. They may struggle with change, and repeat actions over and over. Life may be very anxious or stressful. The signs of autism can occur at any age but often appear in the first two years of life. There is no one type of autism, but many, so the condition is now called autism spectrum disorder (ASD). Autism is lifelong but this study is only about children. Caring for a child with autism can be difficult and can sometimes be tough on the whole family. This project aims to guide the people who plan services for families and children. Different teams and services that do autism assessments will help us. The investigators will ask teams and services: What speeds up diagnosis? What delays diagnosis? The study will be in four work packages:

  1. 1.The investigators will review research in the UK and abroad to find evidence and ideas that will help speed up diagnosis.
  2. 2.The investigators will survey professionals who work for the specialist teams who diagnose autism. The survey will be about each step in the process and ask which professionals get involved. The investigators will ask about the number of children they see and the time it usually takes to reach a diagnosis. This will give us a picture of the national situation.
  3. 3.After the national survey, the investigators will select around six or eight teams. These teams will be using different and innovative approaches. The investigators will study those approaches. The investigators will talk to clinical staff, managers, referrers, parents and young people. Parents and young people will have gone through the diagnostic process. The investigators will ask parents and young people about their experiences and views. The investigators will review the steps in the diagnosis process for about 70 children in each service. The investigators will find out how long each assessment takes, how much clinical time it takes, and how much it costs. The investigators will compare findings across teams and services.
  4. 4.The investigators will have national meetings with autism experts and patient groups. The investigators will show them our findings. These groups will agree recommendations for practice. Clinical teams, service managers, commissioners, parents' groups, and NHS England will receive recommendations.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
520

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 30, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 18, 2020

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

May 6, 2021

Status Verified

May 1, 2021

Enrollment Period

2.6 years

First QC Date

May 18, 2020

Last Update Submit

May 5, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Case Study: Case Note Review - Pathway completion time taken

    Research team monitor steps in the diagnostic pathway. Access child's clinical care records for pathway completion: Time taken from referral to diagnosis/discharge (in days).

    Up to 24 months

Secondary Outcomes (19)

  • Questionnaire: Reported Challenges

    Up to 6 months

  • Questionnaire: Reported Type of Service

    Up to 6 months

  • Questionnaire: Reported New Models of Services

    Up to 6 months

  • Questionnaire: Reported Geographical Area

    Up to 6 months

  • Questionnaire: Reported Activity Levels

    Up to 6 months

  • +14 more secondary outcomes

Other Outcomes (6)

  • Realist Evaluation Outcomes

    Up to 32 months

  • Realist Evaluation Contexts

    Up to 32 months

  • Realist Evaluation Mechanisms

    Up to 32 months

  • +3 more other outcomes

Study Arms (4)

Service Model Level Case Studies

Realist Interviews. MONTHS 9-30 (N=6-8 sites, 12 people per site, 96 interviewees)

Other: Realist evaluation

Individual/family level interviews

Child Interviews. MONTHS 9-30 (N=6-8 sites, 6 people per site, max. 48 interviewees)

Other: Realist evaluation

Individual child/family Level Case Studies:

MONTHS 10-30 (N=6-8 sites, 78 people per model (x4), 312 participants, 156 per NU/SCFT depending on distribution of sites)

Other: Realist evaluation

Focus groups:

MONTHS 9-30 (N=6-8 sites, 6-8 focus groups of up to 8 parents) N= 64

Other: Realist evaluation

Interventions

In-depth exploration of individual service models will be carried out to determine the interrelationship of context, intervention, mechanisms and outcomes as they occur in their natural setting. Data will be gathered within case studies using mixed methods at two levels: (i) service model and (ii) individual child/ family. Methods will include semi structured realist Interviews, focus groups, and document reviews to assemble a comprehensive description of the service and model. Interviewees will include commissioners, service managers, clinicians, referrers, parents and young people. Interviews will be recorded and transcribed, proceeding to qualitative analysis based on components of the programme theory. Regular team meetings will discuss coding, address inconsistencies, and refine collective understanding of coding framework. Coded data will be collated using NVivo software.

Also known as: focus group, health economic questionnaire, survey, Interview, Case note data
Focus groups:Individual child/family Level Case Studies:Individual/family level interviewsService Model Level Case Studies

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Members of staff. referrers, and users of Autism diagnostic services for children.

You may qualify if:

  • Lead clinicians for childhood autism diagnostic assessment teams (children age 1-18 years), or someone who they nominate.

You may not qualify if:

  • Members of staff not involved in Autism diagnostic services.
  • Parents of young people who have been through the diagnostic pathway
  • Young people who have been through the diagnostic pathways
  • Clinicians working in centres involved in the autism diagnostic process
  • Commissioners and managers of autism services; professionals who refer in to the autism pathways
  • Adults on the autism pathway
  • Professionals involved in the adult autism pathway

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nightingale Primary Care Centre

Haywards Heath, West Sussex, RH16 4BN, United Kingdom

RECRUITING

Related Publications (2)

  • Abrahamson V, Zhang W, Wilson PM, Farr W, Reddy V, Parr J, Peckham A, Male I. Realist evaluation of Autism ServiCe Delivery (RE-ASCeD): which diagnostic pathways work best, for whom and in what context? Findings from a rapid realist review. BMJ Open. 2021 Dec 14;11(12):e051241. doi: 10.1136/bmjopen-2021-051241.

  • Abrahamson V, Zhang W, Wilson P, Farr W, Male I. Realist Evaluation of Autism ServiCe Delivery (RE-ASCeD): which diagnostic pathways work best, for whom and in what context? Protocol for a rapid realist review. BMJ Open. 2020 Jul 6;10(7):e037846. doi: 10.1136/bmjopen-2020-037846.

MeSH Terms

Conditions

Autistic DisorderDiseasePatient Satisfaction

Interventions

Focus GroupsSurveys and QuestionnairesInterviews as Topic

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersPathologic ProcessesPathological Conditions, Signs and SymptomsTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Ian Male, Msc MRCP MBBCh

    Sussex Community NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Will Senior Research Fellow, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 18, 2020

First Posted

June 9, 2020

Study Start

November 30, 2019

Primary Completion

June 30, 2022

Study Completion

December 30, 2022

Last Updated

May 6, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will share

IPD data that is anonymised, will be released by the project steering commitee,and only then, IPD data that underlie results in publication will be shared

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Starting September 2023
Access Criteria
Anonymised IPD will be shared if the applicant writes to the project steering committee who will review the request. Access will only be allowed once the study is complete and all publications are complete.

Locations